Acadia Pharmaceuticals reported $-112571000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -112.57M 69.67M
Alnylam Pharmaceuticals ALNY:US $ -239.36M 20.95M
Biogen BIIB:US $ 903.4M 316.6M
Biomarin Pharmaceutical BMRN:US $ 26.19M 92.76M
Bristol Myers Squibb BMY:US $ 5386M 595M
Cara Therapeutics CARA:US $ -27749000 5.63M
Cytokinetics CYTK:US $ -86.75M 56.18M
Eisai 4523:JP Y -20779M 34669M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Intra Cellular Therapies ITCI:US $ -72.11M 13.62M
Johnson & Johnson JNJ:US $ 8218M 1879M
Marinus Pharmaceuticals MRNS:US $ -19.36M 8.94M
Moderna Inc MRNA:US 4.23B 1.18B
Neurocrine Biosciences NBIX:US $ 21.4M 35.2M
Pfizer PFE:US $ 11328M 4083M
Prothena PRTA:US $ -37.96M 4.86M
Ptc Therapeutics PTCT:US $ -121.89M 16.72M
Sarepta Therapeutics SRPT:US $ -104.15M 17.74M
Seattle Genetics SGEN:US $ -135.24M 41.73M
Ultragenyx Pharmaceutical RARE:US $ -151.76M 29.32M
Vanda Pharmaceuticals VNDA:US $ -7.56M 16.17M
YTE INCY:US $ 172.84M 1.75M